000950.SZ · 重药控股
China A-shares · RS rating 62 · As of 2026-10-14
| Price | 5.30 CNY |
|---|---|
| 1-day change | +0.2% |
| RS rating (overall / 1M / 3M / 12M) | 62 / 73 / 61 / 74 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 29 / 32 |
| Industry group (rank) | Medical-Hospitals (29) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +1.0% |
| Distance from 52-week high | +25.8% |
| Market cap (USD) | $1.4B |